Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Public sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Medical marijuana industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Application trends
2.1.3 Route of administration trends
2.1.4 Distribution channel trends
2.1.5 Regional trends
Chapter 3 Medical Marijuana Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing application of marijuana for a myriad of medical conditions and symptoms
3.3.1.2 Growing demand for medical marijuana legalization in several countries
3.3.1.3 Rising number of R&D and clinical trial activities
3.3.2 Industry pitfalls & challenges
3.3.2.1 Few side effects might hinder the market growth
3.3.2.2 Difficulty in medical marijuana business banking
3.4 Growth potential analysis
3.4.1 By application
3.4.2 By route of administration
3.4.3 By distribution channel
3.5 COVID-19 impact analysis
3.6 Value chain analysis
3.7 Legal requirements for distribution of medical marijuana
3.8 Regulatory landscape, by country
3.8.1 U.S.
3.8.2 Canada
3.8.3 The Netherlands
3.8.4 Israel
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Strategic dashboard
Chapter 5 Medical Marijuana Market, By Application
5.1 Key application trends
5.2 Pain management
5.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.2 Neuropathic pain
5.2.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.3 Cancer pain
5.2.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.4 Others
5.2.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.3 Muscle spasms
5.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.4 Nausea
5.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.5 Anorexia
5.5.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.6 Seizures
5.6.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.7 Others
5.7.1 Market estimates and forecast, 2018 – 2032 (USD Million)
Chapter 6 Medical Marijuana Market, By Route of Administration
6.1 Key route of administration trend
6.2 Inhalation
6.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.3 Oral
6.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.4 Topical
6.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
Chapter 7 Medical Marijuana Market, By Distribution Channel
7.1 Key distribution channel trend
7.2 Dispensaries
7.2.1 Market size, by region, 2018 – 2032 (USD Million)
7.3 Online
7.3.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 8 Medical Marijuana Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 Italy
8.3.3 France
8.3.4 Spain
8.3.5 UK
8.3.6 The Netherlands
8.3.7 Denmark
8.3.8 Ireland
8.4 Latin America
8.4.1 Brazil
8.4.2 Mexico
8.4.3 Argentina
8.4.4 Columbia
8.4.5 Chile
8.5 Rest of world
8.5.1 Australia
8.5.2 Thailand
8.5.3 Israel
Chapter 9 Company Profiles
9.1 Canopy Growth Corporation
9.2 Aurora Cannabis, Inc.
9.3 Jazz Pharmaceuticals
9.4 Medical Marijuana, Inc.
9.5 Cannabis Sativa, Inc.
9.6 Emerald Health Therapeutics Inc.
9.7 The Cronos Group Inc.
9.8 Tilray
9.9 Lexaria Bioscience Corp
9.10 Curaleaf
9.11 Green Roads
9.12 CHARLOTTE’S WEB
9.13 Gaia Herbs
9.14 Folium Biosciences
